215 Results for "

Encapsulation

" in MedChemExpress (MCE) Product Catalog:
Products (215)

215 Results for "Encapsulation" in MCE Product Catalog:

Cat. No.: HY-159711
CAS No.: 3097638-12-2
Target:  

Liposome

Research Areas:  

Cancer

PPPDA-O16B is a lipid containing disulfide bonds used for DNA delivery. PPPDA-O16B can encapsulate DNA plasmid, releasing DNA selectively via lipid degradation catalyzed by GSH .
loading...
    loading...
Cat. No.: HY-163957
Target:  

Bacterial

Research Areas:  

Others

Tambjamine LY2 is an algicidal compound with significant algaecidal effects. Bacterial membrane vesicles (BMVs) may be involved in bacteria-algae communication, so BMV encapsulation can be effectively delivered to the microalgae Heterosigma akashiwo and Thalassiosira pseudonana through membrane fusion .
loading...
    loading...
Cat. No.: HY-168943A
PLGA nanoparticles, 200nm, are biodegradable tumor-targeting nanocarriers that can serve as drug delivery enhancers and multidrug resistance inhibitors. PLGA nanoparticles, 200nm, passively enriched through the EPR effect and actively targeted via ligand-mediated endocytosis, can encapsulate various antitumor active molecules. PLGA nanoparticles, 200nm can specifically recognize multiple types of tumor cells and improve cellular uptake, cytotoxicity and antiproliferative effects after modification with ligands such as transferrin, folic acid, and RGD. PLGA nanoparticles, 200nm can encapsulate various therapeutic drugs and can be surface modified to achieve targeting, imaging, and prolonged circulation time, making them suitable for cancer-related research .
loading...
    loading...
Cat. No.: HY-168943B
PLGA nanoparticles, 500nm, are biodegradable tumor-targeting nanocarriers that can serve as drug delivery enhancers and multidrug resistance inhibitors. PLGA nanoparticles, 500nm, passively enriched through the EPR effect and actively targeted via ligand-mediated endocytosis, can encapsulate various antitumor active molecules. PLGA nanoparticles, 500nm can specifically recognize multiple types of tumor cells and improve cellular uptake, cytotoxicity and antiproliferative effects after modification with ligands such as transferrin, folic acid, and RGD. PLGA nanoparticles, 500nm can encapsulate various therapeutic drugs and can be surface modified to achieve targeting, imaging, and prolonged circulation time, making them suitable for cancer-related research .
loading...
    loading...
Cat. No.: HY-W440893
Research Areas:  

Others

DSPE-PEG5000-OH is a linear phospholipid PEG polymer. The lipid tails allow encapsulation of hdyrophobic therapeutics while the PEG chain maintains its hydrophilicity. The polymer can be used for drug nanocarrier, such as liposomal anti cancer drug or mRNA/DNA vaccine.
loading...
    loading...
Cat. No.: HY-167445
PLLA5000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA5000-PEG2000-N3 can be used in drug delivery research .
loading...
    loading...
Cat. No.: HY-167449
PLLA4000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA4000-PEG2000-N3 can be used in drug delivery research .
loading...
    loading...
Cat. No.: HY-177831
Target:  

Liposome

Research Areas:  

Metabolic Disease

Liposomal Vitamin K2 is a specialized delivery system that encapsulates vitamin K2 within tiny liposomes. These liposomes act as protective shells, enhancing the absorption and bioavailability of vitamin K2. Vitamin K2 (menaquinone-7) is?a fat-soluble nut
loading...
    loading...
Cat. No.: HY-W440898
Research Areas:  

Others

DSPE-PEG5000-SH is a polyPEG attached DSPE molecule. The lipid tails allow formation of lipid bilayer in water and can be used to solubilize hydrophobic drugs while the hydrophilic core can encapsulate therapeutic agents, such as nuclein acid (mRNA/DNA), protein or peptide.
loading...
    loading...
Cat. No.: HY-168943C
PLGA nanoparticles, 1μm, are biodegradable tumor-targeting nanocarriers that can serve as drug delivery enhancers and multidrug resistance inhibitors. PLGA nanoparticles, 1μm, passively enriched through the EPR effect and actively targeted via ligand-mediated endocytosis, can encapsulate various antitumor active molecules. PLGA nanoparticles, 1μm can specifically recognize multiple types of tumor cells and improve cellular uptake, cytotoxicity and antiproliferative effects after modification with ligands such as transferrin, folic acid, and RGD. PLGA nanoparticles, 1μm can encapsulate various therapeutic drugs and can be surface modified to achieve targeting, imaging, and prolonged circulation time, making them suitable for cancer-related research .
loading...
    loading...
Cat. No.: HY-185223
CAS No.: 1192362-77-8
Target:  

Liposome

Research Areas:  

Others

A-066 (Formula I) is a cationic lipid. A-066 forms Cationic-Based Lipid Encapsulation Systems (CaBLES) or Lipid-Based Particles. A-066 facilitates delivery of nucleic acids and other agents .
loading...
    loading...
Cat. No.: HY-189053
CAS No.: 303970-80-1
Research Areas:  

Others

AG690 is a phenoloxidase inhibitor and immunosuppressant. AG690 reduces the expression and activity of phenoloxidase, inhibits cellular immune responses including hemocyte phagocytosis, nodule formation and encapsulation, and suppresses the activities of superoxide dismutase (SOD), peroxidase and lysozyme, thereby enhancing the insecticidal toxicity of λ-cyhalothrin against Spodoptera litura larvae. AG690 can be used as an insecticide synergist in related research .
loading...
    loading...
Cat. No.: HY-188106
Target:  

mRNA

Research Areas:  

Metabolic Disease

Human IGF1 mRNA-LNP is a lipid nanoparticle (LNP) encapsulating human IGF1 mRNA. Human IGF1 mRNA encapsulates human insulin-like growth factor 1 (IGF1) protein, which is involved in mediating growth and development.
loading...
    loading...
Cat. No.: HY-185370
Synonyms: Pegylated liposomal doxorubicin; Liposomal doxorubicin; Doxorubicin hydrochloride liposome
Research Areas:  

Cancer

Doxorubicin liposome is a liposome-encapsulated form of doxorubicin hydrochloride (HY-15142). Doxorubicin hydrochloride, a cytotoxic anthracycline antibiotic, is a potent human DNA topoisomerase I and topoisomerase II inhibitor. Compared to traditional doxorubicin, liposome encapsulation reduces its cardiotoxicity and prolongs its circulation time, thus enabling it to effectively target tumor tissue.
loading...
    loading...
Cat. No.: HY-188103
Target:  

mRNA

Research Areas:  

Inflammation/Immunology

Human IL4 mRNA-LNP is a lipid nanoparticle (LNP) encapsulating Human IL4 mRNA. Human IL4 mRNA encapsulates human interleukin 4 (IL4) protein, a pleiotropic cytokine produced by activated T cells that regulates various T and B cell responses, including cell proliferation, survival, and gene expression.
loading...
    loading...
Cat. No.: HY-188107
Target:  

mRNA

Research Areas:  

Inflammation/Immunology

Human CD70 mRNA-LNP is a lipid nanoparticle (LNP) encapsulating human CD70 mRNA. Human CD70 mRNA encapsulates the human CD70 molecule (CD70) protein. CD70 induces co-stimulatory T cell proliferation, enhances the generation of cytolytic T cells, and promotes T cell activation.
loading...
    loading...
Cat. No.: HY-188104
Target:  

mRNA

Research Areas:  

Inflammation/Immunology

Human IL2 mRNA-LNP is a lipid nanoparticle (LNP) encapsulating Human IL2 mRNA. Human IL2 mRNA encapsulates human interleukin 2 (IL2) protein, which belongs to the interleukin 2 (IL2) cytokine subfamily. IL2 is produced by activated CD4+ and CD8+ T lymphocytes and is essential for the proliferation of T cells and B lymphocytes.
loading...
    loading...
Cat. No.: HY-177838
Target:  

Liposome

Research Areas:  

Metabolic Disease

Liposomal Silymarin is a specialized delivery system that encapsulates silymarin within tiny liposomes. These liposomes act as protective shells, enhancing the absorption and bioavailability of silymarin. Silymarin is a natural flavonoid compound derived
loading...
    loading...
Cat. No.: HY-185372
Synonyms: Liposomal mitoxantrone
Target:  

Liposome Topoisomerase PKC

Research Areas:  

Cancer

Mitoxantrone hydrochloride liposome is a liposome-encapsulated Mitoxantrone hydrochloride (HY-13502A) (a topoisomerase II inhibitor). Compared to regular Mitoxantrone hydrochloride, Mitoxantrone hydrochloride liposome enhances antitumor activity and prolongs drug circulation time in the body.
loading...
    loading...
Cat. No.: HY-185371
Synonyms: Irinotecan hydrochlorid liposomee; Liposomal irinotecan
Target:  

Liposome Topoisomerase

Research Areas:  

Cancer

Irinotecan liposome is a liposome-encapsulated form of Irinotecan hydrochlorid (HY-16562A) (a topoisomerase I inhibitor). Compared with Irinotecan, Irinotecan liposome enhances antitumor activity, reduces drug release rate, and avoids neutropenia.
loading...
    loading...